DALLAS, Sept. 21, 2009 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring cosmetic company Hansen Medical Inc. (Nasdaq:HNSN). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
The investment report on Hansen Medical Inc. (Nasdaq:HNSN) should be of particular interest to other medical technologies providers: Boston Scientific Corp. (NYSE:BSX), Johnson & Johnson (NYSE:JNJ), Stereotaxis Inc. (Nasdaq:STXS) and McKesson Corp. (NYSE:MCK).
It is available at: http://www.beaconequity.com/i/HNSN
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity
HNSN engages in the development of advanced technologies and products using robotics to control the position of cardiac catheters. The Company pioneered the Sensei Robotic Catheter system, a robotic navigation system enabling medical clinicians to place catheters in remote parts of the heart more easily and safely during cardiac surgery. Approved by the Food and Drug Administration (FDA) in May 2007, the Sensei Robotics Catheter system is compatible with fluoroscope, ultrasound, 3D surface mapping, and patient electrocardiogram data during Electrophysiology (EP) procedures.
Message Board Search for HNSN: http://www.boardcentral.com/boards/HNSN
In the report, the analyst notes:
"Competition within the industry is also rising, with more multinational companies expanding into each significant market throughout the world. Multinational market penetration, mergers, joint ventures and acquisitions are expected to increase over time. Larger device makers are exploring smaller developing markets to fund future growth in anticipation of rapid growth in the emerging market space.
"On September 15, the Company announced that it received FDA approval for its next generation Sensei Robotic Catheter System. In addition, the Company introduced the Artisan Extend Control Catheter, and released its Lynx Robotic Ablation Catheter to the European market."
To read the entire report visit: http://www.beaconequity.com/i/HNSN
See what investors are saying about these stocks at: http://www.stockhideout.com/
BeaconEquity.com is one of the industry's largest small-cap report providers. Beacon strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com
Beacon Equity Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Beacon Equity nor its affiliates have a beneficial interest in the mentioned company, nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.